The University of Illinois Cancer Center and UICentre, the campuswide drug discovery initiative at the University of Illinois Chicago (UIC), are accepting applications for a third round of grants in their collaborative grant program, known as U2D2, to promote collaboration in cancer drug discovery.
U2D2 is offering seed grants for pilot projects up to $25,000 for a one-year duration related to small-molecule cancer drug discovery. The Principal Investigator must be a Cancer Center member.
Applications must be emailed to [email protected] by 5 p.m. (CDT) on Friday, November 15, 2024.